Enrique Poradosu insider trades
Open-market stock purchases and sales by Enrique Poradosu, Chief Science & Business Off at Nuvectis Pharma, Inc, from SEC Form 4 filings since Feb 4, 2022.
Track record: 100% of 4 scored buys are up 5% or more since purchase, averaging +94%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jan 6, 2026 | NVCT Nuvectis Pharma, Inc | Bought (not open market) | — |
Companies traded
- NVCT Nuvectis Pharma, Inc: 7 buys, last Jan 6, 2026